Showing results (451-460 of 563) with videos related to
Sort By:
Pageof 57
Frontiers in Genetics|January 20, 2022
A Comprehensive Review of the Therapeutic Value of Urine-Derived Stem CellsQian Zhou, Yiyu Cheng, Fang Sun, et al.The Clinical Respiratory Journal|November 10, 2023
Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive-stage small-cell lung cancer patients (DURABLE study)Bo Zhang, Hua Zhong, Chunlei Shi, et al.Bioscience Trends|February 12, 2023
The initiation, exploration, and development of hospital-based health technology assessment in China: 2005 ‒ 2022Mi Tang, Xueyan Zhang, Ziping Ye, et al.International Archives of Occupational and Environmental Health|August 19, 2010
Renal impairment caused by chronic occupational chromate exposureTiancheng Wang, Guang Jia, Ji Zhang, et al.Frontiers in Immunology|June 12, 2023
On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancerAnning Xiong, Jianlin Xu, Shuyuan Wang, et al.Nucleic Acids Research|April 1, 2025
N4-acetylcytidine coordinates with NP1 and CPSF5 to facilitate alternative RNA processing during the replication of minute virus of caninesXueyan Zhang, Shuangkang Qin, Fang Huang, et al.Frontiers in Bioengineering and Biotechnology|March 27, 2020
Gossypium hirsutum Salt Tolerance Is Enhanced by Overexpression of G. arboreum JAZ1Ge Zhao, Yun Song, Qianhua Wang, et al.The Journal of Headache and Pain|December 2, 2022
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI studyZiyu Yuan, Wei Wang, Xueyan Zhang, et al.The Annals of Thoracic Surgery|November 24, 2018
Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung CancerJianlin Xu, Shuyuan Wang, Hua Zhong, et al.Scientific Reports|March 23, 2025
Development and validation of a postoperative prognostic model for hormone receptor positive early stage breast cancer recurrenceRuixin Pan, Haoting Shi, Yiqing Shen, et al.Pageof 57